tiprankstipranks
Inmode (DE:154)
NASDAQ:154
Germany Market

InMode (154) Blogger Opinions & Sentiment

3 Followers

Blogger Sentiment

Bullish: 70.00%
Sector Average
Bullish
DE:154 Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
80% SeekingAlpha
20% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

InMode: It's Time To Exit The Theater (Rating Downgrade)
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

InMode (INMD) Set to Release Q4 Earnings with Positive Expectations
GuruFocus
InMode: Discounted Valuation And Strong Fundamentals Make It A Buy
SeekingAlpha
InMode: Margin Pressure, But Optionality Makes It Worth A Look
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of DE:154?
Seeking Alpha’s Clover Biotech Research has a Bearish Sentiment.
    What do Motley Fool contributors think of DE:154?
    Currently there's no blogger sentiment for DE:154.
    What Is DE:154’s Blogger Sentiment?
    DE:154’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for DE:154?
      The most recent blogger prediction for DE:154 was made by Clover Biotech Research, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          SPHRFStarpharma Holdings Limited
          PRRUFImmutep Ltd
          NURPFNeuren Pharmaceuticals Limited
          CLVLFClinuvel Pharmaceuticals